BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 27960139)

  • 1. Oxidative stress, inflammation and treatment response in major depression.
    Lindqvist D; Dhabhar FS; James SJ; Hough CM; Jain FA; Bersani FS; Reus VI; Verhoeven JE; Epel ES; Mahan L; Rosser R; Wolkowitz OM; Mellon SH
    Psychoneuroendocrinology; 2017 Feb; 76():197-205. PubMed ID: 27960139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum brain-derived neurotrophic factor, Val66Met polymorphism and open-label SSRI treatment response in Major Depressive Disorder.
    Smit AJT; Wu GWY; Rampersaud R; Reus VI; Wolkowitz OM; Mellon SH
    Psychoneuroendocrinology; 2024 Jul; 165():107045. PubMed ID: 38636352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of the Relationship between Inflammation and Oxidative Stress Markers and Treatment Response in First-Attack Major Depression Patients: A Follow-Up Study.
    Emekdar G; Taş Hİ; Şehitoğlu H
    Turk Psikiyatri Derg; 2023; 34(2):89-99. PubMed ID: 37357895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic subgroups for citalopram response in the STAR*D trial.
    Jakubovski E; Bloch MH
    J Clin Psychiatry; 2014 Jul; 75(7):738-47. PubMed ID: 24912106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of duloxetine on changes in serum proinflammatory cytokine levels in patients with major depressive disorder.
    Gao W; Gao Y; Xu Y; Liang J; Sun Y; Zhang Y; Shan F; Ge J; Xia Q
    BMC Psychiatry; 2024 Jun; 24(1):449. PubMed ID: 38877455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-sectional networks of depressive symptoms before and after antidepressant medication treatment.
    Bos FM; Fried EI; Hollon SD; Bringmann LF; Dimidjian S; DeRubeis RJ; Bockting CLH
    Soc Psychiatry Psychiatr Epidemiol; 2018 Jun; 53(6):617-627. PubMed ID: 29627898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Exercise and Sertraline on Measures of Coronary Heart Disease Risk in Patients With Major Depression: Results From the SMILE-II Randomized Clinical Trial.
    Sherwood A; Blumenthal JA; Smith PJ; Watkins LL; Hoffman BM; Hinderliter AL
    Psychosom Med; 2016 Jun; 78(5):602-9. PubMed ID: 26867076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between serum resolvin D1, NLRP3, cytokine levels, and adolescents with first-episode medication-naïve major depressive disorder.
    Guo J; Zhang T; Chen W; Tan J; Li X; Zheng A; Fu Y; Qiu T
    BMC Psychiatry; 2024 Apr; 24(1):285. PubMed ID: 38627683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil to lymphocyte ratio and antidepressant treatment response in patients with major depressive disorder: Effect of sex and hippocampal volume.
    Paolini M; Harrington Y; Raffaelli L; Poletti S; Zanardi R; Colombo C; Benedetti F
    Eur Neuropsychopharmacol; 2023 Nov; 76():52-60. PubMed ID: 37544076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shorter telomere length predicts poor antidepressant response and poorer cardiometabolic indices in major depression.
    Rampersaud R; Wu GWY; Reus VI; Lin J; Blackburn EH; Epel ES; Hough CM; Mellon SH; Wolkowitz OM
    Sci Rep; 2023 Jun; 13(1):10238. PubMed ID: 37353495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Personality traits predict treatment outcome of an antidepressant in untreated adolescents with depression: An 8-week, open-label, flexible-dose study.
    Ran LY; Liu XY; Wang W; Tao WQ; Xiang JJ; Zeng Q; Kong YT; Zhang CY; Liao J; Qiu HT; Kuang L
    J Affect Disord; 2024 Apr; 350():102-109. PubMed ID: 38199422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 8-Iso-prostaglandin F2α as a potential biomarker in patients with unipolar and bipolar depression.
    Lačković M; Stojković T; Pantović Stefanović M; Velimirović Bogosavljević M; Nikolić T; Tomanić M; Nestorović M; Debeljak Martačić J; Petronijević N
    Eur Rev Med Pharmacol Sci; 2023 Dec; 27(23):11496-11507. PubMed ID: 38095397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between peripheral inflammation and free-water imaging in Major Depressive Disorder before and after ketamine treatment - A pilot study.
    Langhein M; Seitz-Holland J; Lyall AE; Pasternak O; Chunga N; Cetin-Karayumak S; Kubicki A; Mulert C; Espinoza RT; Narr KL; Kubicki M
    J Affect Disord; 2022 Oct; 314():78-85. PubMed ID: 35779673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What does plasma CRP tell us about peripheral and central inflammation in depression?
    Felger JC; Haroon E; Patel TA; Goldsmith DR; Wommack EC; Woolwine BJ; Le NA; Feinberg R; Tansey MG; Miller AH
    Mol Psychiatry; 2020 Jun; 25(6):1301-1311. PubMed ID: 29895893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D and inflammation in major depressive disorder.
    Grudet C; Wolkowitz OM; Mellon SH; Malm J; Reus VI; Brundin L; Nier BM; Dhabhar FS; Hough CM; Westrin Å; Lindqvist D
    J Affect Disord; 2020 Apr; 267():33-41. PubMed ID: 32063570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomics profiling reveals inflammatory biomarkers of antidepressant treatment response: Findings from the CO-MED trial.
    Gadad BS; Jha MK; Grannemann BD; Mayes TL; Trivedi MH
    J Psychiatr Res; 2017 Nov; 94():1-6. PubMed ID: 28628884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pro-inflammatory markers are associated with response to sequential pharmacotherapy in major depressive disorder: a CAN-BIND-1 report.
    Husain MI; Foster JA; Mason BL; Chen S; Zhao H; Wang W; Rotzinger S; Rizvi S; Ho K; Lam R; MacQueen G; Milev R; Frey BN; Müller D; Turecki G; Jha M; Trivedi M; Kennedy SH
    CNS Spectr; 2023 Dec; 28(6):739-746. PubMed ID: 37218291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue-Specific Oxysterols as Predictors of Antidepressant (Escitalopram) Treatment Response in Patients With Major Depressive Disorder.
    Sun Z; Yang J; Zhou J; Zhou J; Feng L; Feng Y; He Y; Liu M; Li Y; Wang G; Li R
    Biol Psychiatry Glob Open Sci; 2023 Oct; 3(4):663-672. PubMed ID: 37881566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two polygenic mouse models of major depressive disorders identify TMEM161B as a potential biomarker of disease in humans.
    El Yacoubi M; Altersitz C; Latapie V; Rizkallah E; Arthaud S; Bougarel L; Pereira M; Wierinckx A; El-Hage W; Belzeaux R; Turecki G; Svenningsson P; Martin B; Lachuer J; Vaugeois JM; Jamain S
    Neuropsychopharmacology; 2024 Jun; 49(7):1129-1139. PubMed ID: 38326457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statin for mood and inflammation among adult patients with major depressive disorder: an updated meta-analysis.
    Xiao X; Deng H; Li P; Sun J; Tian J
    Front Psychiatry; 2023; 14():1203444. PubMed ID: 38034928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.